Treatment of Primary Chronic Glomerulonephritis With Immunosuppressive and Anti-Inflammatory Agents

References

• Al-Khader AA, Lien JWK, Aber GM. Cyclophosphamide alone in the treatment of adult patients with minimal change glomerulonephritis. Clin Nephrol 1979; 11: 26–30.
   Google Scholar
• Andrassay K, Waldherr R, Ritz E. Medika-mentöse Behandlung der chronisch verlaufenden Glomerulonephritiden: Contra. Klin Wo-chenschr 1985; 63: 978–987.
   Google Scholar
• Arnaout MA, Rennke HG, Cotran R. Membranous glomerulonephritis. In: Brenner BM, Stein JH, eds. Nephrotic syndrome. New York: Churchill Livingstone, 1982: 199–235.
   Google Scholar
• Bertani T, Remuzzi G. Stagnations and regressions in the treatment of primary glomerulonephritis. Lancet 1983; 2: 90–91.
   Google Scholar
• Cade R, Mars D, Privette M, Thompson R, Croker B, Peterson J, Campbell K. Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids. Arch Intern Med 1986; 146: 737–741.
   Google Scholar
• Cameron JS. Treatment of primary glomerulonephritis using immunosuppressive agents. Am J Nephrol 1989; 9, Suppl 1: 33–40.
   Google Scholar
• Cameron JS. How can we treat glomerulonephritis? Nephrol Dial Transpl 1990; 5 Suppl 1: 16–22.
   Google Scholar
• Cattran DC, Cardella CJ, Roscoe JM, Charron RC, Ranee PC, Ritchie SM, Corey PN. Results of a controlled drug trial in membranoproliferative glomerulonephritis. Kidney Int 1985; 27: 436–441.
   Google Scholar
• Cattran DC. The use of corticosteroids in idiopathic membranous nephropathy. In: Davison AM, ed: Nephrology. Proc Xth Int Congr Nephrology. London: Balliere Tindall, 1988; II: 714–725.
   Google Scholar
• Cattran DC, Delmore T, Roscoe J, Cole E, Cardella C, Charron R, Ritchie S. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. N Engl J Med 1989; 320: 210–215.
   Google Scholar
• Cattran DC, Greenwood C. Severe IgA nephropathy: Potential effects of angiotensin converting enzyme inhibitors vs conventional antihypertensive therapy. Am Soc Nephrol 23rd Annual Meeting, Washington, Dec 1990, p. 305.
   Google Scholar
• Coggins CH. Collaborative study. A controlled study of short-term prednisone treatment in adults with membranous nephropathy. N Engl J Med 1979; 24: 1301–1306.
   Google Scholar
• Donadio JV, Anderson CF, Mitchell JC, Holley KE, Ilstrup DM, Fuster V, Chesebro JH. Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy. N Engl J Med 1984; 310: 1421–1426.
   Google Scholar
• Dworkin LD, Benstein JA. Antihypertensive agents, glomerular hemodynamics and glomerular injury. In: Epstein MA, Loutzenhiser R, eds. Calcium antagonists and the kidney. Philadelphia: Hanley & Delfus, 1990: 155–176.
   Google Scholar
• Garin EH, Orak JK, Hiott KL, Sutherland SE. Cyclosporine therapy for steroid-resistant nephrotic syndrome. A controlled study. AJDC 1988; 142: 985–988.
   Google Scholar
• Goldszer RC, Sweet J, Cotran RS. Focal segmental glomerulosclerosis. Ann Rev Med 1984; 35: 429–449.
   Google Scholar
• International Study of Kidney Disease in Children. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 1981; 98: 560–564.
   Google Scholar
• Jindal K, West M, Bear R, Goldstein M. Long-term benefits of therapy with cyclophoshamide and prednisone in patients with membranous glomerulonephritis and impaired renal function. Am Soc Nephrol 23rd Annual Meeting, Washington, Dec 1990, p. 309.
   Google Scholar
• Kaysen GA, Gambertoglio J, Jimenez I, Jones H, Hutchison FN. Effect of dietary protein intake on albumin homeostasis in nephrotic patients. Kidney Int 1986; 29: 572–577.
   Google Scholar
• Keane W. Anderson S, Aurell M, de Zeeuw D, Narins RG, Povar G. Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions. Ann Int Med 1989; 111: 503–516.
   Google Scholar
• Keane WF. Kasiske BL, O’Donnell MP. Hyper-lipidemia and the progression of renal disease. Am J Clin Nutr 1988; 47: 157–160.
   Google Scholar
• Kobayashi Y, Fujii K. Hiki Y, Tateno S. Steroid therapy in IgA nephropathy: A prospective pilot study in moderate proteinuric cases. Q J Med 1986; 234: 935–943.
   Google Scholar
• Kühn K, Brodehl J, Koch KM, Helmchen U. Medikamentöse Behandlung der chronisch verlaufenden Glomerulonephritiden: Pro. Klin Wo-chenschr 1985; 63: 967–977.
   Google Scholar
• Lai KN, Lai FM, Ho CP, Chan W. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: A long-term controlled trial. Clin Nephrol 1986; 26: 174–180.
   Google Scholar
• Llach F. Hypercoagulability, renal vein thrombosis and other thrombotic complications of nephrotic syndrome. Kidney Int 1985;28:429–439.
   Google Scholar
• Matousovic I, Matl I, Zabka J, Zástava V, Ross-man P, Prát V. Effect of combined immunosuppressive, anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis. Czech Med 1985; 8: 151–157.
   Google Scholar
• McEnery PT, McAdams AJ, West CD. The effect of prednisone in a high-dose, alternate-day regimen on the natural history of idiopathic membranoproliferative glomerulonephritis. Medicine 1986; 64: 401–424.
   Google Scholar
• Meyrier A, Simon P. Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: Minimal-change disease and focal segmental glomerulosclerosis. Adv Nephrol 1988: 17: 127–150.
   Google Scholar
• Meyrier A. Treatment with cyclosporin of patients with idiopathic nephrotic syndrome. Springer Semin Immunopathol 1987; 9: 441–450.
   Google Scholar
• Mulec H, Johnson S-A, Björck S. Relation between scrum cholesterol and diabetic nephropathy. Lancet 1990; 1: 1537–1538.
   Google Scholar
• Nolasco F, Cameron JS, Heywood EF et al. Adult-onset minimal change nephrotic syndrome: a long-term follow-up. Kidney Int 1986; 29: 1215–1223.
   Google Scholar
• Ponticelli C, Fogazzi GB. Methylprednisolone pulse therapy for primary glomerulonephritis. Am J Nephrol 1989; 9, Suppl 1: 41–46.
   Google Scholar
• Ponticelli C, Zucchelli P, Passerini P et al. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 1989; 320: 8–13.
   Google Scholar
• Schena FP, Montenegro M, Scivittaro V. Meta-analysis of randomised controlled trials in patients with primary IgA nephropathy (Berger’s disease). Nephrol Dial Transplant 1990; Suppl 1: 47–52.
   Google Scholar
• van Acker KJ, Egli FR, Lennert T et al. Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Lancet 1988; 2: 380–383.
   Google Scholar
• Wehrmann M, Bohle A, Bogenschütz O ct al. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes. Clin Nephrol 1989; 31: 67–76.
   Google Scholar
• Williams SA, Makker SP, Ingelfinger JR. Gruppe WE. Long-term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood. N Engl J Med 1980; 302: 929–933.
   Google Scholar
• Williams PS, Bone JM. Immunosuppression can arrest progressive renal failure due to idiopathic membranous glomerulonephritis. Nephrol Dial Transplant 1989; 4: 181–186.
   Google Scholar
• Woo KT, Edmonson RPS, Yap HK, et al. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis. Clin Nephrol 1987; 27: 56–64.
   Google Scholar
• Woo KT, Chiang GSC, Yap HK, Lim Ch. Controlled therapeutic trial of IgA nephritis with follow-up renal biopsies. Ann Acad Med 1988; 17: 226–231.
   Google Scholar